GE Healthcare News

1. Innovation And Automation Are Driving Forces Behind Next Generation Cell Therapy Manufacturing Platform From Cytiva 5/30/2024
2. Precision NanoSystems And Aurora Vaccines Join Forces To Accelerate The Development Of Vaccine Candidate For Hepatitis C Virus 6/23/2023

   Global leader in non-viral delivery of genomic medicines, Precision NanoSystems (PNI), entered into a strategic collaboration agreement with Aurora Vaccines to accelerate the development and manufacture of its Hepatitis C vaccine candidate. PNI will share its expertise in the development of the RNA payload platform and its proprietary lipid nanoparticle (LNP) platforms to help bring Aurora’s RNA-LNP vaccine candidate for the prevention of Hepatitis C virus (HCV) infection to a Phase I clinical trial.

3. Precision NanoSystems And Replicate Bioscience In Licensing Deal To Scale Up Genomic Medicines 7/26/2022

   In a move that signifies the heightened focus on mRNA as a key tool in human health, Precision NanoSystems (PNI) and Replicate Bioscience will enter a licensing agreement to accelerate the creation, scale-up, and delivery of self-replicating RNA (srRNA) therapies.

4. Cytiva And Multiply Labs Collaborate To Automate Cell Therapy Manufacturing 5/26/2021

   Cytiva, a global life sciences leader, and Multiply Labs, a leader in developing robotic systems for pharmaceutical manufacturing, are collaborating to develop a robotic manufacturing system that will automate the manual portions of the cell therapy manufacturing workflow. Creating a fully automated system that can operate at an industrial scale will enable the speed and flexibility that is needed to manufacture these next generation therapeutics.

5. Cytiva And Brooks Life Sciences To Enhance Automation In Cold Chain Solutions 2/16/2021

   Cytiva, a global life sciences leader, and Brooks Life Sciences, a division of Brooks Automation, are working together to expand Cytiva’s Chronicle software capabilities to seamlessly integrate Brooks Life Sciences BioStore III automated storage platform, which is purpose built to handle a wide range of high value materials between the temperatures of -20°C and -190°C in an efficient, documented way. Chronicle software will provide a unified digital platform that can electronically trace cellular products and raw materials through the cell therapy workflow including the cryogenic cold chain.

6. G-CON Manufacturing And GE Healthcare Announce Collaboration To Advance Early-Stage Cell Therapy And Viral Vector Manufacturing 1/21/2019

   G-CON Manufacturing, the leader in prefabricated flexible cleanroom solutions (“PODs”) and GE Healthcare plan to collaborate to improve cell therapy and viral vector manufacturing by providing drug developers with a combined, flexible, and readily deployable manufacturing platform suitable for early-stage clinical or commercial production.

7. Scaling Up Cell Therapy Manufacturing In Guangzhou 9/4/2018

   GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T Cell Immunotherapy Drugs.

8. GE Healthcare Life Sciences Opens Cell And Gene Therapy Asia Technology Center In Shanghai 8/31/2018

   Building GE Healthcare's first cell and gene therapy laboratory in Asia, the center aims to enable new developments and commercialization of precision medicine in Asia.